Two Sigma Advisers’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-274,000
| Closed | -$191K | – | 2752 |
|
|
2023
Q1 | $191K | Buy |
274,000
+121,700
| +80% | +$85K | ﹤0.01% | 2278 |
|
|
2022
Q4 | $137K | Buy |
152,300
+117,500
| +338% | +$106K | ﹤0.01% | 2253 |
|
|
2022
Q3 | $209K | Sell |
34,800
-2,800
| -7% | -$16.8K | ﹤0.01% | 2186 |
|
|
2022
Q2 | $156K | Sell |
37,600
-29,000
| -44% | -$120K | ﹤0.01% | 2324 |
|
|
2022
Q1 | $253K | Sell |
66,600
-21,400
| -24% | -$81.3K | ﹤0.01% | 2302 |
|
|
2021
Q4 | $396K | Sell |
88,000
-47,300
| -35% | -$213K | ﹤0.01% | 2029 |
|
|
2021
Q3 | $630K | Sell |
135,300
-47,200
| -26% | -$220K | ﹤0.01% | 1829 |
|
|
2021
Q2 | $1.29M | Sell |
182,500
-39,700
| -18% | -$280K | ﹤0.01% | 1518 |
|
|
2021
Q1 | $1.31M | Buy |
222,200
+29,500
| +15% | +$174K | ﹤0.01% | 1498 |
|
|
2020
Q4 | $888K | Sell |
192,700
-24,300
| -11% | -$112K | ﹤0.01% | 1616 |
|
|
2020
Q3 | $844K | Buy |
+217,000
| New | +$844K | ﹤0.01% | 1576 |
|